Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Krait venom neurotoxins are a family of protein toxins found in the venom of kraits (Bungarus species), highly venomous snakes in the family Elapidae[4]. Notable types include α-bungarotoxin, κ-bungarotoxin (both "three-finger toxins" acting primarily on postsynaptic nicotinic acetylcholine receptors), and β-bungarotoxin (a heterodimeric toxin of phospholipase A2 and a Kunitz-type inhibitor, acting presynaptically)[1][4]. α- and κ-bungarotoxins bind to nAChRs, blocking synaptic transmission at the neuromuscular junction and within the nervous system; β-bungarotoxin targets voltage-sensitive potassium channels and disrupts acetylcholine release from presynaptic terminals[4]. These neurotoxins are the main drivers of the rapid-onset paralysis and potentially fatal respiratory effects observed in krait envenomation[1]. Their structure, actions, and ability to specifically affect neurotransmission at both muscular and neuronal synapses have made them important research tools in neurobiology but they are not considered traditional drug targets themselves—rather, they are the "active components" of envenomation for which antivenoms are developed[4][5].
Postsynaptic antagonism of nicotinic acetylcholine receptor (α-bungarotoxin, κ-bungarotoxin), Presynaptic inhibition of acetylcholine release (β-bungarotoxin via phospholipase A2 activity and binding to potassium channels)
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Krait venom neurotoxin.